Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.93 |
| ▸ | HTR2C | P28335 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 4/20 | 0.50 |
| ▸ | PNMT | P11086 | 1/20 | 0.50 |
| ▸ | CD44 | P16070 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 3/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.46 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.46 |
| ▸ | BAD | Q92934 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | DRD1 | P21728 | 1/20 | 0.42 |
| ▸ | DRD4 | P21917 | 1/20 | 0.42 |
| ▸ | DRD5 | P21918 | 1/20 | 0.42 |
| ▸ | DRD3 | P35462 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | PLAU | P00749 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11645158 | 0.96 | TSHR (1.00) | TSHRHTR2CMAOBPNMTCD44 | |
| SCHEMBL385555 | 0.96 | TSHR (1.00) | TSHRHTR2CMAOBPNMTCD44 | |
| SCHEMBL27692545 | 0.96 | TSHR (1.00) | TSHRHTR2CMAOBPNMTCD44 | |
| SCHEMBL11606739 | 0.96 | TSHR (1.00) | TSHRHTR2CMAOBPNMTCD44 | |
| SCHEMBL8355 | 0.96 | TSHR (1.00) | TSHRHTR2CMAOBPNMTCD44 | |
| SCHEMBL29358070 | 0.96 | TSHR (1.00) | TSHRHTR2CMAOBPNMTCD44 | |
| Phosphine SCHEMBL15313264 | 0.93 | TSHR (0.93) | TSHRHTR2CMAOBPNMTCD44 | |
| Cyclohexane SCHEMBL10948412 | 0.93 | TSHR (0.93) | TSHRHTR2CMAOBPNMTCD44 | |
| SCHEMBL16393911 | 0.93 | TSHR (0.93) | TSHRHTR2CMAOBPNMTCD44 | |
| Hydrochloric Acid SCHEMBL5800421 | 0.93 | TSHR (0.93) | TSHRHTR2CMAOBPNMTCD44 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025245301-A1 | HIGH PURITY BIS (ARENE) METAL COMPLEXES | ENTEGRIS, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| US-20250361254-A1 | HIGH PURITY BIS (ARENE) METAL COMPLEXES | ENTEGRIS INC (US) | 2025-11-27 | — | — | US | disclosed |
| EP-4476233-A1 | ORGANOMETALLIC PRECURSORS AND RELATED METHODS | Entegris, Inc. (US) | 2024-12-18 | — | — | EP | disclosed |
| CN-118804919-A | Organometallic precursors and related methods | 恩特格里斯公司 | 2024-10-18 | — | — | CN | disclosed |
| US-20230271987-A1 | ORGANOMETALLIC PRECURSORS AND RELATED METHODS | ENTEGRIS, INC. | 2023-08-31 | — | — | US | disclosed |
| WO-2023154404-A1 | ORGANOMETALLIC PRECURSORS AND RELATED METHODS | ENTEGRIS, INC. (US) | 2023-08-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250361254-A1 | HIGH PURITY BIS (ARENE) METAL COMPLEXES | FHIT, AP2M1, AP1M1 | TSHR 4751/4885HTR2C 3075/4885MAOB 1710/4885 |
| US-20230271987-A1 | ORGANOMETALLIC PRECURSORS AND RELATED METHODS | APC, TPR, INTS9 | TSHR 4662/4885HTR2C 3731/4885MAOB 2881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.